Pharma Journalist 9027 posts 0 comments

Novartis announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to 177Lu-PSMA-617, an investigational radioligand therapy for the…
Read More...

SMi reports: Discussions will be centered around improving targeted therapy uniting the field’s biggest players to share their opinions From optimizing particle size to choosing the…
Read More...

SMi Reports: Workshop will include case studies related to emergent digital health innovations currently coming out of Silicon Valley, software apps connected to drug delivery…
Read More...

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, announce it has entered into a research collaboration with Novo…
Read More...

United Therapeutics Corporation  announced that the U.S. Food and Drug Administration (FDA) accepted for priority review the New Drug Application (NDA) for Tyvaso DPI™ (inhaled…
Read More...

PulmoSIM Therapeutics (PulmoSIM), the pharmaceutical subsidiary of VeriSIM Life, Inc., is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted orphan drug…
Read More...

Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical company and pioneer in the development of cellular immunotherapy, has established and invested in its new contract…
Read More...

New data from Public Health England (PHE) demonstrated COVID-19 Vaccine AstraZeneca offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian’…
Read More...

NRx Pharmaceuticals a clinical stage pharmaceutical company, announced positive data from its ZYESAMI™ (Aviptadil) Expanded Access Protocol (EAP). Overall, patients receiving at least…
Read More...

Today, the U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers)…
Read More...